rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 14

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-00753 · 2002

Ghrelin's Metabolic Effects Beyond GH: Appetite, Fat Storage, and Cardiovascular Actions

Ghrelin's peripheral metabolic actions — orexigenic signaling, adipogenic activity, and cardiovascular protection — establish it as a master metabolic coordinator with therapeutic targets for obesity, cachexia, and cardiovascular disease.

Muccioli, Giampiero; Tschöp, Matthias; Papotti, Mauro; Deghenghi, Romano; Heiman, Mark; Ghigo, Ezio · Review

RPEP-00755 · 2002

Adrenomedullin Versus BNP as Heart Function Markers in Dialysis Patients

Mature adrenomedullin and BNP provided complementary cardiac information in hemodialysis patients: BNP reflected LV dysfunction more specifically, while mAM reflected broader cardiovascular status including vascular and renal components.

Osajima, Akihiko; Okazaki, Masahiro; Tamura, Masahito; Anai, Hirofumi; Kabashima, Narutoshi; Suda, Takeshi; Iwamoto, Masako; Ota, Takayuki; Watanabe, Yuujiro; Kanegae, Kaori; Nakashima, Yasuhide · Cross Sectional

RPEP-00765 · 2002

In Chickens, Ghrelin Does the Opposite: It DECREASES Appetite Instead of Increasing It

Intracerebroventricular chicken ghrelin and GHRP-2 inhibited food intake in neonatal chicks — the opposite of the appetite-stimulating effect in mammals — revealing a fundamental species difference in ghrelin signaling.

Saito, Ei-suke; Kaiya, Hiroyuki; Takagi, Tomo; Yamasaki, Izumi; Denbow, D Michael; Kangawa, Kenji; Furuse, Mitsuhiro · Animal Study

RPEP-00768 · 2002

Macrocyclic Versions of Natural Antimicrobial Peptides: Broad-Spectrum Antibiotics That Resist Bacterial Defenses

Macrocyclic hairpin mimetics of protegrin I demonstrated broad-spectrum antibacterial activity including against resistant strains, with improved stability over linear peptide antibiotics and activity maintained in challenging conditions.

Shankaramma, Sasalu C; Athanassiou, Zafiria; Zerbe, Oliver; Moehle, Kerstin; Mouton, Carole; Bernardini, Francesca; Vrijbloed, Jan W; Obrecht, Daniel; Robinson, John A · In Vitro

RPEP-00770 · 2002

The Hypothalamic GH Secretagogue Receptor Controls Both Growth Hormone and Body Weight

Hypothalamic GHS-R antisense knockdown reduced both GH secretion and body weight/food intake in rats, confirming the hypothalamic receptor's dual role in mediating GH release and appetite regulation by ghrelin/GHS.

Shuto, Yujin; Shibasaki, Tamotsu; Otagiri, Asuka; Kuriyama, Hideki; Ohata, Hisayuki; Tamura, Hideki; Kamegai, Jun; Sugihara, Hitoshi; Oikawa, Shinichi; Wakabayashi, Ichiji · Animal Study

RPEP-00771 · 2002

BPC-157 Reverses Chronic Amphetamine-Induced Behavioral Disturbances in Rats

BPC-157 attenuated chronic amphetamine-induced tolerance, behavioral sensitization, and withdrawal disturbances in rats, demonstrating comprehensive dopamine system stabilization against stimulant drug-induced neuroplasticity.

Sikiric, Predrag; Jelovac, Nikola; Jelovac-Gjeldum, Andjelka; Dodig, Goran; Staresinic, Mario; Anic, Tomislav; Zoricic, Ivan; Rak, Davor; Perovic, Darko; Aralica, Gorana; Buljat, Gojko; Prkacin, Ingrid; Lovric-Bencic, Martina; Separovic, Jadranka; Seiwerth, Sven; Rucman, Rudolf; Petek, Marijan; Turkovic, Branko; Ziger, Tihomil; Boban-Blagaic, Alenka; Bedekovic, Vlado; Tonkic, Ante; Babic, Slaven · Animal Study

RPEP-00775 · 2002

Chronic Arthritis Pain Rewires the Brain's Opioid System Differently at Each Level

Chronic arthritic pain produced region-specific alterations in dynorphin B, met-enkephalin, and opioid receptor levels across brain, spinal cord, and pituitary, demonstrating multi-level opioid system adaptation to chronic inflammatory pain.

Spetea, Mariana; Rydelius, Gustav; Nylander, Ingrid; Ahmed, Mahmood; Bileviciute-Ljungar, Indre; Lundeberg, Thomas; Svensson, Stefan; Kreicbergs, Andris · Animal Study

RPEP-00778 · 2002

Big Dynorphin Causes Pain Through NMDA Receptors, Not Opioid Receptors

Intrathecal big dynorphin at femtomole doses caused nociceptive behavior through NMDA receptor activation (blocked by MK-801) but not through opioid receptors (not blocked by naloxone), with higher doses causing reversible paralysis.

Tan-No, Koichi; Esashi, Akihisa; Nakagawasai, Osamu; Niijima, Fukie; Tadano, Takeshi; Sakurada, Chikai; Sakurada, Tsukasa; Bakalkin, Georgy; Terenius, Lars; Kisara, Kensuke · Animal Study

RPEP-00784 · 2002

Each Opioid Peptide Modulates Different Pain Phases at Different Spinal Levels

Phase- and level-specific pain modulation: beta-endorphin supraspinal/early phase; enkephalins spinal/late phase; dynorphin both levels/both phases — the most detailed mapping of endogenous opioid pain control organization.

Wu, Hsiang-En; Hung, Kuei-Chun; Mizoguchi, Hirokazu; Nagase, Hiroshi; Tseng, Leon F · Animal Study

RPEP-00786 · 2003

How Synthetic Peptides Made HIV Testing More Accurate

Synthetic peptides designed to mimic HIV viral proteins proved sufficiently sensitive and specific for diagnosing HIV infection through ELISA (enzyme-linked immunosorbent assay) tests. These peptide-based diagnostics could reliably detect HIV-specific antibodies in AIDS patients and — importantly — could distinguish between HIV-1 and HIV-2 infections, as well as differentiate between various HIV subtypes. The review catalogues the most important peptide antigens developed for HIV immunodiagnosis, showing how synthetic peptides derived from key viral epitopes became practical tools for serological testing.

Alcaro, Maria Claudia; Peroni, Elisa; Rovero, Paolo; Papini, Anna Maria · Review

RPEP-00788 · 2003

Epitalon Peptide Extended Lifespan by 12% and Reduced Cancer in Aging Mice

Subcutaneous Epitalon injections (0.1 µg per mouse, 5 consecutive days per month starting at 3 months of age) in female SHR mice increased both mean and maximum lifespan by 12.3% compared to untreated controls. The peptide did not increase total spontaneous tumor incidence but significantly decreased the incidence of malignant lymphomas. Additionally, Epitalon preserved estrous cycle function longer, slowed age-related deterioration of immune parameters, and reduced the frequency of chromosome aberrations in bone marrow cells of old mice.

Anisimov, V N; Khavinson, V Kh; Popovich, I G; Zabezhinski, M A; Alimova, I N; Rosenfeld, S V; Zavarzina, N Yu; Semenchenko, A V; Yashin, A I ·

RPEP-00790 · 2003

BNP: From Laboratory Discovery to Essential Clinical Heart Failure Tool

BNP has evolved from a research peptide to an essential clinical tool for heart failure diagnosis, prognosis, screening, and treatment monitoring, with particularly high value in emergency department dyspnea differentiation.

Azzazy, Hassan M E; Christenson, Robert H · Review

RPEP-00792 · 2003

BPC-157 Heals Duodenal Ulcers Differently Depending on Whether Salivary Glands Are Present

BPC-157 maintained duodenal ulcer healing after sialoadenectomy while cimetidine and ranitidine lost effectiveness, demonstrating BPC-157's independence from salivary gland-derived protective factors — a unique pharmacological property.

Bedekovic, Vlado; Mise, Stjepan; Anic, Tomislav; Staresinic, Mario; Gjurasin, Miroslav; Kopljar, Mario; Kalogjera, Livije; Drvis, Petar; Boban Blagaic, Alenka; Batelja, Lovorka; Seiwerth, Sven; Sikiric, Predrag · Animal Study

RPEP-00793 · 2003

Heart Failure Disrupts the Normal Pulsatile Rhythms of ANP and BNP Secretion

Heart failure disrupted the normal pulsatile secretion patterns of both ANP and BNP, with BNP rhythm abnormalities correlating with disease severity — adding temporal pattern analysis to biomarker diagnostics.

Bentzen, Hans; Pedersen, Robert S; Pedersen, Henrik B; Nyvad, Ole; Pedersen, Erling B · Clinical Trial

RPEP-00794 · 2003

BNP and Endothelin Predict Heart Failure Death at Different Disease Stages

BNP best predicted short-term outcomes in mild-moderate heart failure, while endothelin was more prognostic in advanced heart failure and over longer follow-up, demonstrating stage- and time-dependent prognostic value of neurohormonal biomarkers.

Berger, Rudolf; Strecker, Karin; Huelsmann, Martin; Moser, Petra; Frey, Bernhard; Bojic, Anja; Stanek, Brigitte; Pacher, Richard · Cohort

RPEP-00796 · 2003

Macrocyclic Peptides Designed to Trap Bacterial DNA Junctions as Novel Antibiotics

Macrocyclic peptides designed to bind Holliday DNA junctions showed antibacterial activity, validating a completely novel antibiotic mechanism targeting bacterial DNA repair/recombination.

Bolla, Megan L; Azevedo, Enrique V; Smith, Jason M; Taylor, Rachel E; Ranjit, Dev K; Segall, Anca M; McAlpine, Shelli R · In Vitro

RPEP-00801 · 2003

Discovery of Capromorelin: An Orally Active GH Secretagogue With High Potency and Bioavailability

Capromorelin showed potent GHS-R binding (Ki=7 nM), oral GH-releasing activity in rats, 60% oral bioavailability in dogs, and IGF-1 elevation with repeated dosing, emerging as a clinical development candidate.

Carpino, Philip A; Lefker, Bruce A; Toler, Steven M; Pan, Lydia C; Hadcock, John R; Cook, Ewell R; DiBrino, Joseph N; Campeta, Anthony M; DeNinno, Shari L; Chidsey-Frink, Kristin L; Hada, William A; Inthavongsay, John; Mangano, F Michael; Mullins, Michelle A; Nickerson, David F; Ng, Oicheng; Pirie, Christine M; Ragan, John A; Rose, Colin R; Tess, David A; Wright, Ann S; Yu, Li; Zawistoski, Michael P; DaSilva-Jardine, Paul A; Wilson, Theresa C; Thompson, David D · Animal Study

RPEP-00804 · 2003

PYY3-36 From the Gut Suppresses Appetite by Changing Brain Hunger Gene Expression

Peripheral PYY3-36 acutely suppressed food intake and altered hypothalamic neuropeptide expression (decreased NPY, increased POMC) in mice, confirming it as a gut-derived satiety signal that modulates central appetite gene programs.

Challis, B G; Pinnock, S B; Coll, A P; Carter, R N; Dickson, S L; O'Rahilly, S · Animal Study

RPEP-00807 · 2003

Gastric Pacing for Obesity Changes Gut Peptide and Leptin Levels

Gastric pacing in morbidly obese patients altered circulating CCK, somatostatin, and leptin levels, providing a neuroendocrine mechanism for the satiety and weight loss effects of this device.

Cigaina, Valerio; Hirschberg, Angelica L · Clinical Trial

RPEP-00810 · 2003

Ghrelin and GHRP-6 Cross-React With the Motilin Receptor, Linking GH and Gut Motility

Bidirectional cross-reactivity between ghrelin/GHRP-6 and the motilin receptor was demonstrated: ghrelin activated the motilin receptor and motilin activated GHS-R, linking GH regulation and gut motility at the receptor level.

Depoortere, Inge; Thijs, Theo; Thielemans, Leen; Robberecht, Patrick; Peeters, Theo L · In Vitro

RPEP-00811 · 2003

Lactoferrin's Anti-Adenovirus Activity Depends on Its Heparin-Binding Sites

Lactoferrin's anti-adenovirus activity was mediated through its heparin-interacting domains, which compete with viral attachment to cell surface heparan sulfate — a mechanism explaining its broad antiviral spectrum against heparan sulfate-binding viruses.

Di Biase, Assunta Maria; Pietrantoni, Agostina; Tinari, Antonella; Siciliano, Rosa; Valenti, Piera; Antonini, Giovanni; Seganti, Lucilla; Superti, Fabiana · In Vitro

RPEP-00813 · 2003

The Complete Guide to Gut Signals That Control Hunger and Fullness

Satiety is controlled by a two-tier peripheral signaling system: short-term gut peptides (CCK, GLP-1, PYY, ghrelin, oxyntomodulin) for meal control and long-term adiposity signals (leptin, insulin) for body weight regulation, integrated by brainstem and hypothalamic circuits.

Drazen, Deborah L; Woods, Stephen C · Review

RPEP-00817 · 2003

Ghrelin and Synthetic GH Secretagogues Protect Rat Hearts From Ischemic Damage

Ghrelin, hexarelin, and EP-80317 improved cardiac contractile recovery after ischemia in isolated rat hearts, with effects on coronary perfusion pressure, while MK-677 showed less cardioprotection — suggesting peptide GHS are preferred cardiac protectants.

Frascarelli, Sabina; Ghelardoni, Sandra; Ronca-Testoni, Simonetta; Zucchi, Riccardo · Animal Study

RPEP-00818 · 2003

A New Heart Damage Marker Combined With BNP Improves Risk Assessment in Dialysis Patients

The hFABP/myoglobin ratio combined with BNP improved detection of cardiac damage and volume overload in dialysis patients, providing a multi-marker approach that overcomes renal clearance confounding of individual markers.

Furuhashi, Masato; Ura, Nobuyuki; Hasegawa, Koichi; Yoshida, Hideaki; Tsuchihashi, Kazufumi; Nakata, Tomoaki; Shimamoto, Kaxuaki · Cross Sectional